Back to Search
KATHERINE KESTER, MD
MD
Pediatrics Physician
NPI: 1255906996Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
79090(CT)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
78328-RES(CT)
Research & Publications (20)
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.
PMID 19390585·PLoS One·2009
3-trial
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
PMID 19649245·PLoS One·2009
3-trial
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.
PMID 19569965·J Infect Dis·2009
3-trial
Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia.
PMID 19276646·Hum Vaccin·2009
4-observational
Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice.
PMID 18455276·Vaccine·2008
7-preclinical
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research.
PMID 18387719·Vaccine·2008
3-trial
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
PMID 16388879·Vaccine·2007
3-trial
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.
PMID 17574311·Vaccine·2007
3-trial
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
PMID 17442466·Vaccine·2007
3-trial
Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques.
PMID 16911849·Vaccine·2006
4-observational
Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.
PMID 16904798·Vaccine·2006
7-preclinical
Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya.
PMID 16837726·Am J Trop Med Hyg·2006
3-trial
Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria.
PMID 16988231·Infect Immun·2006
8-other
Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
PMID 16574282·Vaccine·2006
7-preclinical
Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.
PMID 16356603·Vaccine·2006
3-trial
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
PMID 15755604·Vaccine·2005
6-review
Investigating the effect of the zwitterion/lactone equilibrium of rhodamine B on the cybotactic region of the acetonitrile/scCO2 cosolvent.
PMID 16833502·J Phys Chem A·2005
8-other
Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children.
PMID 15964483·Vaccine·2005
3-trial
Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.
PMID 15364429·Vaccine·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 20 YORK ST
NEW HAVEN, CT 06510 - Phone
- (203) 688-4242
Quick Facts
- NPI
- 1255906996
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile